Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 7Active not recruiting 4Terminated 1Enrolling by invitation 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 51Breast Neoplasms 40Colorectal Neoplasms 26Prostatic Neoplasms 22Lung Neoplasms 18Carcinoma, Non-Small-Cell Lung 15Carcinoma, Hepatocellular 15Stomach Neoplasms 14Brain Neoplasms 11Hematologic Neoplasms 10Pancreatic Neoplasms 9Colonic Neoplasms 9Uterine Cervical Neoplasms 8Urinary Bladder Neoplasms 8Lymphoma, Follicular 8Head and Neck Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Ovarian Neoplasms 7Melanoma 7Liver Neoplasms 7Leukemia, Myeloid, Acute 7Disease 7Anxiety Disorders 7Myasthenia Gravis 6Multiple Myeloma 6Barrett Esophagus 6Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Rectal Neoplasms 5Lymphoma, Non-Hodgkin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × von Hippel-Lindau Disease × 1 year × Clear all
NCT00102544 2026-06-01

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

National Institutes of Health Clinical Center (CC)

Phase NA Enrolling by invitation
3,894 enrolled
Genitourinary

Adenocarcinoma, Carcinoma, Renal Cell, von Hippel-Lindau Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡